Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,471 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07842575Recruiting
Questionnaire to measure fear of movement due to urinary incontinence
This study is testing a new questionnaire that measures fear of movement related to urinary incontinence. By answering questions, you can help doctors better understand and treat this condition.
Kırşehir, KırşehirAges 18 years+ - NCT06362122Recruiting
Severe nasal polyps: links between symptoms, tissue, and blood
This study looks at people with severe nasal polyps that need surgery (ethmoidectomy) for the first time. Researchers want to understand the connection between your symptoms, nasal tissue, and blood tests.
PoitiersAges 18 years+ - NCT07834476Enrolling by invitation
Setting treatment targets for severe head injury in children
This study looks at information from children who had a serious head injury. It uses data from special brain monitors to help doctors decide how to best manage these injuries.
Cambridge, CambridgeshireAges 1 month–18 years - NCT07839234Enrolling by invitation
Personalized breathing support for lung injury patients
This trial tests a new way to adjust breathing machine settings for people with a lung condition called ARDS. The adjustments are based on detailed monitoring of the heart and lungs, aiming to improve recovery.
Xiamen, FujianAges 18 years+ - NCT07828210RecruitingPhase 4
Mild to moderate stroke recovery study
This study tests a daily supplement called NeuroAiD to see if it helps people recover after a mild or moderate stroke. It looks at how well patients feel and function in their daily life during recovery.
Ho Chi Minh CityAges 18–80 - NCT07833696Recruiting
Study of severe hives that don't respond to omalizumab
This study looks at people with severe hives (chronic urticaria) that have not improved with the usual dose of the medicine omalizumab. It aims to better understand these cases and how they are managed, which may help improve future care.
Besançon, Franche-comtéAges 18–80 - NCT07826936RecruitingEarly Phase 1
Nerve block for severe abdominal pain in the emergency department
This trial tests whether a nerve block can provide better pain relief for severe abdominal pain that hasn't improved with standard pain medicine. It's for people who are not candidates for surgery and are in the emergency department or already in the hospital.
Orange, CaliforniaAges 18 years+ - NCT05095857RecruitingPhase 4
Ketamine to improve care in severe acute brain injury
This Phase 4 trial tests whether giving ketamine during anesthesia is safe and helpful for adults with severe sudden brain injuries after surgery. It may improve how patients are sedated and cared for while they are on a breathing machine.
CopenhagenAges 18 years+ - NCT07820371Recruiting
Perfusion index for diabetic ketoacidosis severity in the emergency department
This study looks at a simple, non-invasive measurement called the perfusion index, which shows how well blood is flowing to your tissues, to help doctors quickly determine how severe diabetic ketoacidosis (a serious diabetes complication) is. The goal is to see if this measurement can guide treatment and improve outcomes.
Ankara, AnkaraAges 18 years+ - NCT07819656Recruiting
Predicting severe blood cell drops in nasopharyngeal cancer
This study looks at how likely it is for people with nasopharyngeal carcinoma to experience a severe drop in blood cell counts (myelosuppression) during treatment. By tracking risk, doctors may be better able to prevent or manage this side effect.
Guangzhou, GuangdongAges 18 years+ - NCT07811869RecruitingPhase 3
Remibrutinib for severe itchy skin with unknown cause
This study tests a new medicine called remibrutinib to see if it can reduce severe itching that has no clear cause. It aims to help people whose daily itching is very intense and not relieved by standard creams.
Tampa, FloridaAges 18 years+ - NCT07810192Recruiting
Compression stockings for leg veins during long flights after surgery
This trial tests whether wearing a certain type of compression stocking during a long economy-class flight helps prevent veins in the legs from widening after plastic surgery. If you are planning such a trip, the study may help you recover more safely and comfortably.
BogotáAges 18–65 - NCT06491121Recruiting
Can high-intensity training with a smartphone help chronic back pain?
This trial tests if a technology-supported high-intensity exercise program can help adults with chronic low back pain. You'll use your own smartphone to help guide the training and attend regular therapy sessions.
Wilrijk, AntwerpenAges 18–65 - NCT07813806Recruiting
Care coordination for adults with intellectual disabilities
This trial tests a team-based approach to help adults with intellectual disabilities manage their health and daily life. It may improve their quality of life and independence.
Hong KongAges 18–60 - NCT07813910Recruiting
Two-step sinus lift for upper jaw implants
This study tests a two-stage method to build up bone in the upper jaw for dental implants using either donor bone or a mix of your own bone and donor bone. It may help people with very little bone in the back of the upper jaw get implants successfully.
Giza, Giza GovernorateAges 18–70 - NCT06499246Recruiting
Parathyroid transplant for severe low calcium after thyroid removal
This trial tests a parathyroid gland transplant for people with severe, long-term low calcium levels after thyroid removal. It aims to help those who still have symptoms despite high-dose calcium and vitamin D supplements.
Toronto, OntarioAges 19 years+ - NCT07803965RecruitingPhase 2
Study of an injection for severe acute pancreatitis
This trial tests an investigational medicine called SGC001 given as an injection to people with severe acute pancreatitis, a serious inflammation of the pancreas. The study aims to see if the drug is safe and helpful, and to gather early information on how it works.
ChengduAges 18–75 - NCT07807046Recruiting
Guided atracurium dosing in ICU patients
This trial tests whether using a device to guide the dosing of atracurium (a muscle relaxant) improves outcomes in critically ill ICU patients who need this medication for more than 48 hours. It focuses on patients with severe lung or heart conditions, such as ARDS or ECMO support.
New Taipei CityAges 20 years+ - NCT07805590Recruiting
How respiratory viruses interact in hospitalized patients
This study looks at how different respiratory viruses interact in hospitalized patients during the winter seasons. It does not involve any new treatment or extra tests – it just reviews existing test results to learn more about these viruses.
Lyon, RhoneAges Any age - NCT04490317Recruiting
Study follows people with carbon monoxide poisoning in Korea
This study looks at people who have been sickened by carbon monoxide (CO) from an accident or exposure. It aims to better understand what happens over time, which could help improve care and outcomes in the future.
Wŏnju, Gangwon-doAges Any age - NCT07795502Recruiting
Tracking infections in cancer patients with sepsis
This study watches how infections grow and respond to treatment in cancer patients who may have sepsis. It aims to find better ways to diagnose and monitor sepsis early, which could improve care and outcomes.
Sohag, Sohag GovernorateAges 18 years+ - NCT05874674Recruiting
Testing nafamostat to reduce bleeding risk during dialysis
This pilot study tests whether nafamostat is safe for people on hemodialysis who have a high risk of bleeding. It may help clinicians find safer ways to manage blood clotting medicines during dialysis.
Wŏnju, KangwondoAges 18–99 - NCT06143137Recruiting
Long-term recovery after septic shock treatment
This study checks on people who had septic shock and were in the ReActIF-ICE trial. It looks at how their immune system recovered over time after an experimental therapy.
MagdeburgAges 18–80 - NCT07789106Recruiting
CoQ10 for fatigue and strength in GLP-1 users
This study tests whether Coenzyme Q10 (CoQ10) can help reduce fatigue and improve muscle strength in people who are taking GLP-1 medications for weight management. You will be asked to take a daily supplement (CoQ10 or placebo) for a period and track your progress via a smartphone app.
GlasgowAges 30–65
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,471 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.